EP Biocomposites Ltd (EPBIO.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-185.4%

-₹75.13

vs ₹88.00 price

Levered DCF

-₹565.75

After debt service

Piotroski score

7 / 9

Strong

Altman Z-score

3.2

Safe zone

Rating

Overall 4 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	9.97×	19.73×	20.61×	48.22×	20.02×	19.9×	1,000×	0×
P/B	1.21×	1.92×	2.48×	3.3×	8.11×	18.43×	249.13×	0×
P/S	1.07×	1.69×	2.07×	3.89×	2.01×	2.42×	2.09×	0×
EV / EBITDA	6.21×	11.52×	14.84×	25.05×	14.58×	15.16×	162.69×	0×
Gross margin	36.6%	35.7%	38.7%	42.2%	38.3%	38.3%	15.6%	0.0%
Operating margin	15.7%	13.9%	17.5%	12.3%	22.2%	22.3%	14.2%	0.0%
Net margin	10.7%	8.6%	10.0%	8.1%	10.0%	12.1%	5.6%	0.0%
Current ratio	3.34×	3.95×	2.84×	4.45×	1.73×	1.39×	1.06×	1.06×
Debt / equity	0.2×	0.28×	0.19×	0.15×	2.06×	0×	0.09×	0.09×
Interest coverage	6.28×	4.69×	57.45×	4.33×	11.45×	0×	1,610×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	12.1%	9.7%	12.0%	6.8%	40.5%	92.6%	662.9%	0.0%
Return on invested capital	11.1%	8.9%	12.9%	6.4%	19.9%	131.3%	1136.0%	0.0%
Return on assets	7.8%	6.2%	7.6%	4.9%	8.7%	27.0%	34.4%	0.0%
Free cash flow yield	9.6%	-2.5%	-6.2%	-2.9%	-29.3%	0.4%	9.8%	0.0%
Earnings yield	10.0%	5.1%	4.8%	2.1%	5.0%	5.0%	2.7%	0.0%
Enterprise value	₹147.8M	₹217M	₹242.4M	₹268.4M	₹201.7M	₹69.8M	₹70.1M	-₹1.1M
Net debt / EBITDA	0.1×	0.72×	0.33×	-0.85×	2.86×	-0.32×	-2.63×	0×
Cash conversion cycle (days)	268	302	219	285	247	41	-12	0